VANGUARD GROUP INC - AILERON THERAPEUTICS INC ownership

AILERON THERAPEUTICS INC's ticker is and the CUSIP is 00887A204. A total of 20 filers reported holding AILERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of AILERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$60,700
-16.2%
39,934
-1.3%
0.00%
Q2 2023$72,447
-1.1%
40,473
-31.5%
0.00%
Q1 2023$73,282
-76.3%
59,099
-54.6%
0.00%
Q4 2022$308,847130,3150.00%
Other shareholders
AILERON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 830,466$1,262,3082.16%
KCK LTD. 22,341$33,9580.05%
VANGUARD GROUP INC 39,934$60,7000.00%
JFS WEALTH ADVISORS, LLC 1,590$2,4170.00%
US BANCORP \DE\ 1,250$1,9000.00%
BANK OF AMERICA CORP /DE/ 125$1900.00%
WELLS FARGO & COMPANY/MN 24$360.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 56,513$85,3340.00%
MORGAN STANLEY 1,250$1,9000.00%
View complete list of AILERON THERAPEUTICS INC shareholders